Cerola Pringle
Psychiatry · Mesa, AZNPI 1750642153
Payments from drug & device makers
Across 126 payments — averaging $27.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$923
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$288
- Vanda Pharmaceuticals Inc.$276
- Otsuka America Pharmaceutical, Inc.$268
- Johnson & Johnson$263
- AbbVie$254
- plus $1K from 19 others
What the payments were for
- Travel & lodging$47714%
- Food & beverage$2,95286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 9 | $923 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $288 |
| Vanda Pharmaceuticals Inc. | 9 | $276 |
| Otsuka America Pharmaceutical, Inc. | 13 | $268 |
| Johnson & Johnson | 12 | $263 |
| AbbVie(2 entities) | 14 | $254 |
| Neurocrine Biosciences, Inc. | 3 | $178 |
| Alkermes, Inc. | 9 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $152 |
| Lundbeck LLC | 7 | $139 |
| Corium, LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Ironshore Pharmaceuticals Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Bausch Health US, LLC | 2 | $40 |
| Blue Earth Diagnostics | 1 | $29 |
| Tris Pharma Inc | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 2 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY$581
- Fanapt$125
- INGREZZA$118
How this compares
$3,428 in reported general payments places this provider in the 85th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 38 | $317 |
| Bupropion XlBupropion Hcl | 17 | $293 |
| Clonazepam | 46 | $287 |
| Mirtazapine | 23 | $278 |
| Duloxetine Hcl | 11 | $235 |
| Lamotrigine | 16 | $227 |
| Quetiapine Fumarate | 12 | $219 |
| Trazodone Hcl | 23 | $111 |
| Escitalopram Oxalate | 11 | $109 |
| Sertraline Hcl | 17 | $93 |
| Alprazolam | 25 | $61 |
| Lorazepam | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Mesa
- Payam SadrMesa$487K
- Bahar GolestanMesa$234K
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Katherine KelleyChandler$610K
- Steven BuppTucson$451K
- Monica BenavidezPhoenix$435K
- Ahmed ElmaadawiPhoenix$395K
- Lee KelleyPhoenix$340K
- Shahzad AliTucson$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.